Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Home »
Pharmacology » 7-TM Receptors » Peptide Receptors » Glucagon and Related Receptors » GIP Receptor » GIP (1-39)
GIP (1-39)Cat. No. 2257 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Alternative Name: Gastric Inhibitory Polypeptide (1-39) |
Biological Activity
Endogenous truncated form of the incretin hormone GIP. More potent at stimulating glucose-dependent insulin secretion from rat pancreatic β-cells than GIP (Cat. No 2084).Technical Data
M.Wt:4633.21
Formula:C210H316N56O61S
Sequence:YAEGTFISDYSIAMDKIRQQDFVNWLLAQKGKKSDWKHN
Solubility:Soluble to 10 mg/ml in water
Storage:Desiccate at -20°C
CAS No:725474-97-5
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet
References
Xie et al (2004) GIP1-39, a novel insulinotropic peptide form and aspects on its mechanism of action. Regul.Peptides 121 107.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: GIP (1-39), supplier, potent, insulinotropic, peptide, Gastric, inhibitory, Peptide, Receptors, Glucose-Dependent, Insulinotropic, GIP, Glucagon
Quick Order
Find multiple products by catalog number
Tocris Events
Win a Kindle
5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders
June 23 - 26, 2013
Bath, UK





